UNIVERSITY OF MARYLAND BALTIMORE
Advanced Development of a Combined Shigella-ETEC Vaccine
Advanced Development of a Combined Shigella-ETEC Vaccine is a funding opportunity from UNIVERSITY OF MARYLAND BALTIMORE, up to 1117865, closing May 31, 2028.
May 31, 2028
(670d left)Overview
Program Director/Principal Investigator (Last, First, Middle): Barry, Eileen M. Project Summary Shigella and enterotoxigenic Escherichia coli (ETEC) are two of the most important diarrheal pathogens worldwide, causing significant disease in young children in developing countries and in U.S. travelers, including…